Seeking Alpha

NuVasive (NUVA +4.5%) pops on a Baird upgrade to outperfrom. Baird cites its proprietary survey...

NuVasive (NUVA +4.5%) pops on a Baird upgrade to outperfrom. Baird cites its proprietary survey of spine/neurosurgeons suggesting spine market dynamics are somewhat flat, but the industry's conversion to lateral lumbar fusion creates an opportunity for NuVasive to gain market share.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)